Cas:91296-86-5 Difluoxacin hydrochloride manufacturer & supplier

We serve Chemical Name:Difluoxacin hydrochloride CAS:91296-86-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Difluoxacin hydrochloride

Chemical Name:Difluoxacin hydrochloride
CAS.NO:91296-86-5
Synonyms:MFCD03840489;6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,hydrochloride
Molecular Formula:C21H20ClF2N3O3
Molecular Weight:435.852
HS Code:

Physical and Chemical Properties:
Melting point:>245ºC (dec.)
Boiling point:595.5ºC at 760 mmHg
Density:1.409 g/cm3
Index of Refraction:1.629
PSA:65.78000
Exact Mass:435.116119
LogP:3.52380

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD03840489 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD03840489 Use and application,6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,hydrochloride technical grade,usp/ep/jp grade.


Related News: This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. Difluoxacin hydrochloride manufacturer The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine. Difluoxacin hydrochloride supplier The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine. Difluoxacin hydrochloride vendor Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Difluoxacin hydrochloride factory As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics.